4//SEC Filing
Kennedy Giulia C 4
Accession 0001384101-22-000145
CIK 0001384101other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 5:02 PM ET
Size
8.2 KB
Accession
0001384101-22-000145
Insider Transaction Report
Form 4
VERACYTE, INC.VCYT
Kennedy Giulia C
Chief Scientific & Med Officer
Transactions
- Exercise/Conversion
Common Stock
2022-11-11$14.34/sh+2$29→ 68,003 total - Sale
Common Stock
2022-11-11$29.34/sh−2$59→ 68,001 total - Exercise/Conversion
Stock Option (right to buy)
2022-11-11−2→ 0 totalExercise: $14.34Exp: 2024-02-18→ Common Stock (2 underlying)
Footnotes (2)
- [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022.
- [F2]The option is fully vested.
Documents
Issuer
VERACYTE, INC.
CIK 0001384101
Entity typeother
Related Parties
1- filerCIK 0001769333
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 5:02 PM ET
- Size
- 8.2 KB